Interleukin(IL)-17-producing RORγt + γδ T (γδT17) cells develop in the embryonic thymus and 16 participate in type 3 immune responses. Herein we show that γδT17 cells rapidly proliferate within 17 neonatal lymph nodes and gut, where upon entry they uniquely upregulate Tbet and co-express IL-18 17, IL-22 and interferon(IFN) γ in a STAT3 and retinoic acid dependent manner. Neonatal 19 expansion was halted in mice conditionally deficient in STAT5 and its loss resulted in γδT17 cell 20 depletion from all adult organs. Hyperactive STAT5 mutant mice showed that the STAT5A 21 homologue had a dominant role over STAT5B in promoting γδT17 cell expansion and 22 downregulating gut-associated Tbet. In contrast, STAT5B preferentially expanded IFNγ-producing 23 γδ populations. Importantly, mice lacking γδT17 cells due to STAT5 deficiency displayed a 24 profound resistance to experimental autoimmune encephalomyelitis. Our data identify for the first 25 time STAT5 as a key molecular checkpoint allowing γδT17 cells to pass through a critical neonatal 26 developmental window to acquire tissue-specific characteristics essential for infection and 27 autoimmunity.
Introduction

29
Interleukin(IL)-17 producing gamma delta (γδ) T cells (γδT17) are one of the major type 3 innate 6 constitutive expression of hyperactive STAT5B increased the numbers of CD27 + γδ T but had a 141 smaller effect on γδT17 cells ( Fig. 2A-B ). When we analyzed cytokine expression we found that 142 IFNγ was only induced by hyperactive STAT5B (Fig. S2E) , whereas IL-17A could be induced at 143 high levels both by hyperactive STAT5A as well as WT STAT5B expression ( Fig. 2C ). However, 144 hyperactive STAT5B did not induce IL-17A expression ( Fig. 2C) .
145
Similar to the LN, skin γδT17 cell numbers were greatly enhanced by hyperactive STAT5A 146 whereas STAT5B had a milder impact ( Fig. 2D-E) . With the exception of Vγ5 + dendritic epidermal 147 T cells, CCR6 + γδT17 cells are the only γδ population in the skin. However, mice expressing 148 hyperactive STAT5B, and to a lesser extent mice expressing hyperactive STAT5A, contained 149 CCR6 − γδ T cells that were either Vγ4 + or Vγ4 − (Fig. 2D-F (Petermann et al., 2010; Sutton et al., 2009 ) and we therefore 156 investigated how well RORγt CRE -STAT5 F/F mice responded to MOG (myelin oligodendrocyte 157 glycoprotein)-induced EAE. We found that compared to littermate controls, RORγt CRE -STAT5 F/F 158 mice were resistant to EAE symptoms (Fig. 3A ). This correlated with significantly reduced γδT17 159 cells in the LN and brain at days 11 and 21 after immunization . As expected, γδ T cell 160 associated IL-17A production was significantly reduced at all time points in mice lacking STAT5 161 ( Fig. 3E ). Although it has been recently suggested that inflammatory conditions during EAE can de 162 novo regenerate γδT17 cells (Papotto et al., 2017a) , our data suggest that in the absence of 163 STAT5, γδT17 cell regeneration cannot occur.
164
It has been shown that in addition to their direct contribution to EAE pathogenesis, γδT17 cells 165 are required for optimal Th17 responses (Sutton et al., 2009) . We therefore interrogated the CD4 +
166
T cell response in the LN and brain of RORγt CRE -STAT5 F/F and littermate control mice during EAE.
167
We found that the numbers and cytokine production of CD4 + T cells were not affected in the LN 7 ( Fig. S1C-D) , which may be a reflection of the levels of STAT5 still detectable in these cells (Fig. 169 S1A). As expected from the clinical score and the lack of pro-inflammatory γδT17 cells, there was 170 a profound reduction in CD4 + T cell numbers within the brain of RORγt CRE -STAT5 F/F mice ( Fig. 3F ).
171
Collectively, our data show that loss of γδT17 cells due to STAT5 deficiency is associated with 172 dramatically reduced inflammatory responses in the EAE model. 
176
Besides the skin and peripheral lymphoid tissues, γδ T cells with type 3 functionality have been 177 described in the mucosa such as the lung and gut (Sheridan et al., 2013; Sutherland et al., 2014) .
178
We therefore wanted to test whether STAT5 regulated γδT17 cells specifically in the intestinal 179 lamina propria (LP). In order to avoid potential differences in γδT17 surface markers in the gut, we 180 stained small intestinal and colonic LP (sLP and cLP respectively) for RORγt and Tbet and 181 compared this to peripheral LNs. Surprisingly, we found that many RORγt + γδ T cells in the gut co-182 expressed Tbet (Fig. 4A ). We additionally confirmed the presence of RORγt + Tbet + γδ T cells by 183 generating double transgenic mice reporting GFP and AmCyan under control of the promoters for 184 RORγt and Tbet, respectively ( Fig S3A) . By transcription factor staining analysis we found that the 185 RORγt + Tbet + γδ T cell population was more prevalent in the ileum and proximal colon ( Fig. 4B ), 186 which contrasted with the distribution of RORγt − Tbet + γδ T cells in the same locations ( Fig. S3B ).
187
In order to investigate which factors regulate the expression of Tbet, we analyzed mice deficient in 188 Toll-like receptor and IL-12 signaling as well as mice depleted of their intestinal microbial flora. We 189 found that expression of Tbet was independent of the microbiota (Fig. S3C ), MyD88, TRIF and IL-190 12 signaling ( Fig. S3D ).
191
In agreement with their innate nature, intestinal γδT17 cells produced IL-17A, IL-22 and IFNγ 192 as early as 7 days after birth ( Fig. 4C ), indicating a functional γδT17 population that has acquired 193 the ability to produce IFNγ at steady-state. Using RORγt CRE -STAT3 F/F mice, we showed that 194 production of both IL-17A and IL-22 was STAT3-dependent ( Fig. 4D -E and S4A-B). One of the key 195 factors regulating IFNγ-expressing cells is retinoic acid (RA) (Brown et al., 2015) . We therefore 
217
Next, we sought to determine whether STAT5 also regulated RORγt + Tbet + γδ T cells 218 neonatally. We therefore analyzed neonatal gut at different time points and found that 1-2 days 219 after birth γδ T cells in the colon and small intestine expressed either RORγt or Tbet but not both 
245
STAT5 is a major signaling component downstream of many cytokine and growth factor 246 receptors and is therefore involved in the development of lymphocyte lineages (Rani and Murphy, 247 2016). Hence, both mice and humans with STAT5-associated deficiencies are severely 248 immunocompromized (Imada et al., 1998; Kofoed et al., 2003) . T cells of the γδ lineage are 249 reduced in the thymus and lymphoid tissues of full STAT5-deficient mice (Hoelbl et al., 2006) , and 250 this has been attributed to a failure to successfully rearrange the TCR early during embryonic 251 development (Wagatsuma et al., 2015) . However, our data show that γδT17 cells require STAT5 10 signaling to expand and survive after they exit the thymus. This suggests that γδ T cell subsets rely 253 on STAT5 during different steps of their development and differentiation, presumably reflecting 254 cytokine niches within the local microenvironment.
255
Detailed molecular and phenotypic studies utilizing mice deficient in either STAT5A or 256 STAT5B have shown that despite their many commonalties, particularly at the genome-wide level, imprinted by the specific tissue cues present in different locations. It is thus not surprising that the 299 immunological response of different γδ T cell subsets will vary and will be essential or redundant 300 depending on the inflammatory or infectious context.
301
In summary, we provide evidence that the neonatal microenvironment, acting in synergy with 
